Host DNA contents in fecal metagenomics as a biomarker for intestinal diseases and effective treatment
Abstract Background Compromised intestinal barrier (CIB) has been associated with many enteropathies, including colorectal cancer (CRC) and inflammatory bowel disease (IBD). We hypothesized that CIB could lead to increased host-derived contents including epithelial cells into the gut, change its phy...
Main Authors: | Puzi Jiang, Senying Lai, Sicheng Wu, Xing-Ming Zhao, Wei-Hua Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | BMC Genomics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12864-020-6749-z |
Similar Items
-
Colorectal Cancer Stage-Specific Fecal Bacterial Community Fingerprinting of the Taiwanese Population and Underpinning of Potential Taxonomic Biomarkers
by: Chuan-Yin Fang, et al.
Published: (2021-07-01) -
Oral and Fecal Microbiota in Lynch Syndrome
by: Roberto Ferrarese, et al.
Published: (2020-08-01) -
An Integrated Outlook on the Metagenome and Metabolome of Intestinal Diseases
by: Wanping Aw, et al.
Published: (2015-11-01) -
Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria Analysis
by: Shaobo Mo, et al.
Published: (2021-02-01) -
Metagenomic Characterization of the Human Intestinal Microbiota in Fecal Samples from STEC-Infected Patients
by: Federica Gigliucci, et al.
Published: (2018-02-01)